NEW YORK (GenomeWeb News) - Invitrogen said yesterday that it has purchased two molecular probe product lines from TEF Labs.
The purchase gives Invitrogen TEF Labs' fluo3 and fluo4 product lines and all related intellectual property. Invitrogen's Molecular Probes business will assume the manufacture and sale of fluo 3 and fluo 4.
TEF Labs divested the product lines in order to "focus our resources on the development of new products and technologies," said Akwasi Minta, CEO of TEF Labs, in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.